Health
U.S. to pay $1 billion for 100 million doses of Johnson & Johnson’s COVID-19 vaccine candidate – Investing.com
U.S. to pay $1 billion for 100 million doses of Johnson & Johnson’s COVID-19 vaccine candidate
By Michael Erman
(Reuters) – The United States government will pay Johnson & Johnson (N:JNJ) over $1 billion for 100 million doses of its potential coronavirus vaccine, as it stocks up on vaccine and drugs in an attempt to tame the pandemic.
The latest contract is priced at roughly $10 per vaccine dose produced by J&J, or around $14.50 per dose, including a previous $456 million the U.S. government promised to J&J for vaccine development in March. That compares with the $19.50 per …
-
Noosa News19 hours agoCommissioner thanks police officer who threw a speed radar at a car
-
Noosa News17 hours agoNo matter what happens in his Origin debut, history beckons for rookie maroon Robert Toia
-
Noosa News18 hours agoDefence investigation finds Taipan pilot’s actions possibly prevented further fatalities in crash
-
Noosa News18 hours agoGood character references restricted in rape cases in Queensland